QQQ   445.30 (-0.07%)
AAPL   174.24 (-3.02%)
MSFT   415.98 (+0.12%)
META   504.03 (+0.34%)
GOOGL   132.36 (-3.49%)
AMZN   178.81 (+0.33%)
TSLA   189.75 (-6.36%)
NVDA   853.69 (+3.76%)
NIO   5.41 (-6.40%)
AMD   208.18 (+2.73%)
BABA   72.05 (-3.44%)
T   16.94 (-0.24%)
F   12.99 (+4.34%)
MU   96.76 (+1.69%)
CGC   3.02 (-5.92%)
GE   159.85 (+0.76%)
DIS   112.94 (+0.88%)
AMC   4.34 (-0.46%)
PFE   25.85 (-2.78%)
PYPL   59.43 (-1.83%)
XOM   104.29 (-1.46%)
QQQ   445.30 (-0.07%)
AAPL   174.24 (-3.02%)
MSFT   415.98 (+0.12%)
META   504.03 (+0.34%)
GOOGL   132.36 (-3.49%)
AMZN   178.81 (+0.33%)
TSLA   189.75 (-6.36%)
NVDA   853.69 (+3.76%)
NIO   5.41 (-6.40%)
AMD   208.18 (+2.73%)
BABA   72.05 (-3.44%)
T   16.94 (-0.24%)
F   12.99 (+4.34%)
MU   96.76 (+1.69%)
CGC   3.02 (-5.92%)
GE   159.85 (+0.76%)
DIS   112.94 (+0.88%)
AMC   4.34 (-0.46%)
PFE   25.85 (-2.78%)
PYPL   59.43 (-1.83%)
XOM   104.29 (-1.46%)
QQQ   445.30 (-0.07%)
AAPL   174.24 (-3.02%)
MSFT   415.98 (+0.12%)
META   504.03 (+0.34%)
GOOGL   132.36 (-3.49%)
AMZN   178.81 (+0.33%)
TSLA   189.75 (-6.36%)
NVDA   853.69 (+3.76%)
NIO   5.41 (-6.40%)
AMD   208.18 (+2.73%)
BABA   72.05 (-3.44%)
T   16.94 (-0.24%)
F   12.99 (+4.34%)
MU   96.76 (+1.69%)
CGC   3.02 (-5.92%)
GE   159.85 (+0.76%)
DIS   112.94 (+0.88%)
AMC   4.34 (-0.46%)
PFE   25.85 (-2.78%)
PYPL   59.43 (-1.83%)
XOM   104.29 (-1.46%)
QQQ   445.30 (-0.07%)
AAPL   174.24 (-3.02%)
MSFT   415.98 (+0.12%)
META   504.03 (+0.34%)
GOOGL   132.36 (-3.49%)
AMZN   178.81 (+0.33%)
TSLA   189.75 (-6.36%)
NVDA   853.69 (+3.76%)
NIO   5.41 (-6.40%)
AMD   208.18 (+2.73%)
BABA   72.05 (-3.44%)
T   16.94 (-0.24%)
F   12.99 (+4.34%)
MU   96.76 (+1.69%)
CGC   3.02 (-5.92%)
GE   159.85 (+0.76%)
DIS   112.94 (+0.88%)
AMC   4.34 (-0.46%)
PFE   25.85 (-2.78%)
PYPL   59.43 (-1.83%)
XOM   104.29 (-1.46%)

Acasti Pharma (ACST) Earnings Date, Estimates & Call Transcripts

$3.45
+0.01 (+0.29%)
(As of 11:20 AM ET)

Earnings Summary

Upcoming
Earnings Date
Jun. 28Estimated
Actual EPS
(Feb. 12)
-$0.21 Beat By $0.02
Consensus EPS
(Feb. 12)
-$0.23
Skip Charts & View Estimated and Actual Earnings Data

ACST Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ACST Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Acasti Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.63)($0.63)($0.63)
Q2 20241($0.29)($0.29)($0.29)
Q3 20241($0.30)($0.30)($0.30)
Q4 20241($0.35)($0.35)($0.35)
FY 20244($1.57)($1.57)($1.57)

ACST Earnings Date and Information

Acasti Pharma last posted its earnings results on February 12th, 2024. The biopharmaceutical company reported ($0.21) EPS for the quarter, beating the consensus estimate of ($0.23) by $0.02. Acasti Pharma has generated ($5.08) earnings per share over the last year (($5.08) diluted earnings per share). Earnings for Acasti Pharma are expected to grow in the coming year, from ($1.44) to ($1.29) per share. Acasti Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, June 28th, 2024 based off prior year's report dates.

Acasti Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
6/28/2024
Estimated)
------- 
2/12/2024Q4 2023($0.23)($0.21)+$0.02($0.21)--
11/13/2023Q2 2024($0.29)($0.19)+$0.10$0.05--
8/11/2023Q1 2024($0.63)($0.34)+$0.29($0.14)--
6/23/2023Q4 2023($0.78)($0.30)+$0.48$3.30--
2/14/2023Q3 2023($0.78)($0.54)+$0.24($0.09)--
11/14/2022Q2 2023-($0.66)($0.66)($0.11)--  
8/11/2022Q1 2023-($0.60)($0.60)($0.10)--
6/21/2022Q4 2022($0.78)($0.24)+$0.54($0.04)--
2/14/2022Q3 2022($0.48)($0.54)($0.06)($0.09)--
11/10/2021Q2 2022-$0.18+$0.18$0.03--
8/12/2021Q1 2022-($0.48)($0.48)($0.08)--
6/22/2021Q4 2021-($1.44)($1.44)($0.03)--












Acasti Pharma Earnings - Frequently Asked Questions

When is Acasti Pharma's earnings date?

Acasti Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, June 28th, 2024 based off last year's report dates. Learn more on ACST's earnings history.

Did Acasti Pharma beat their earnings estimates last quarter?

In the previous quarter, Acasti Pharma (NASDAQ:ACST) reported ($0.21) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.23) by $0.02. Learn more on analysts' earnings estimate vs. ACST's actual earnings.

How much revenue does Acasti Pharma generate each year?

Acasti Pharma (NASDAQ:ACST) has a recorded annual revenue of $200,000.00.

How much profit does Acasti Pharma generate each year?

Acasti Pharma (NASDAQ:ACST) has a recorded net income of -$42.43 million. ACST has generated -$5.08 earnings per share over the last four quarters.

What is Acasti Pharma's EPS forecast for next year?

Acasti Pharma's earnings are expected to grow from ($1.44) per share to ($1.29) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ACST) was last updated on 3/4/2024 by MarketBeat.com Staff